» Authors » Yoshie Onishi

Yoshie Onishi

Explore the profile of Yoshie Onishi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 155
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Arai Y, Okuyama K, Onishi Y, Schelfhout J, Tokita S, Kubo T
BMC Pulm Med . 2022 Nov; 22(1):429. PMID: 36411418
Background: Although unmet medical needs for better care of patients with chronic cough exist in Japan, epidemiological information about these patients and their treatments is very limited. Objectives: To describe...
2.
Igarashi A, Ishida K, Shoji N, Chu A, Falvey H, Han R, et al.
Int J Ophthalmol . 2022 Jul; 15(6):954-961. PMID: 35814897
Aim: To evaluate the cost-utility of iStent with cataract surgery cataract surgery alone in patients with mild-to-moderate primary open angle glaucoma (POAG) in the Japanese setting from a public payer's...
3.
Soen S, Kaku M, Okubo N, Onishi Y, Saito K, Kobayashi M
J Bone Miner Metab . 2022 May; 40(4):636-647. PMID: 35546370
Introduction: Glucocorticoid-induced osteoporosis (GIOP) is associated with elevated fracture risk. Practice guidelines have been published to reduce this risk but are insufficiently followed in everyday practice. The objectives of this...
4.
Kiyohara Y, Matsuzaki T, Teng L, Kishida M, Kanakubo A, Motrunich A, et al.
Dermatol Ther (Heidelb) . 2022 Apr; 12(4):1041-1054. PMID: 35397733
Introduction: Molecular targeted therapies (MTTs) cause skin disorders in patients with cancer, and moisturizers are useful treatments; however, their actual use and costs are unknown. Our purpose was to examine...
5.
Dronova M, Ikeoka H, Itsumura N, Hirotsu N, Ansaripour A, Aballea S, et al.
Curr Med Res Opin . 2021 Apr; 37(7):1135-1148. PMID: 33858277
Objective: Baloxavir marboxil (baloxavir) is a single-dose antiviral which was previously found to be a cost-effective alternative to laninamivir in otherwise healthy adults in Japan. This study aimed at investigating...
6.
Skrzeczek A, Ikeoka H, Hirotsu N, Ansaripour A, Aballea S, Onishi Y, et al.
J Infect Chemother . 2020 Nov; 27(2):296-305. PMID: 33243614
Background: Baloxavir marboxil (baloxavir) is a new oral antiviral for influenza types A and B. Objectives: To determine the cost-effectiveness of baloxavir versus laninamivir in otherwise healthy (OwH) adults in...
7.
Igarashi A, Fukuda A, Teng L, Ma F, Dorey J, Onishi Y
J Mark Access Health Policy . 2020 Mar; 8(1):1720068. PMID: 32128076
: Dementia has become a growing health-care problem in the rapidly ageing Japanese population. This study assesses the impact of dementia on quality of life, economic burden, and productivity loss....
8.
Nishimura R, Kato H, Kisanuki K, Oh A, Hiroi S, Onishi Y, et al.
BMJ Open . 2019 Mar; 9(3):e025806. PMID: 30826768
Objective: To determine real-world trends in antidiabetic drug use, and persistence and adherence, in Japanese patients with type 2 diabetes mellitus (T2DM). Design: Retrospective evaluation of administrative claims data (2011-2015)...
9.
Wake M, Oh A, Onishi Y, Guelfucci F, Shimasaki Y, Teramoto T
Atherosclerosis . 2019 Jan; 282:19-28. PMID: 30669019
Background And Aims: Real-world data on treatment patterns in Japanese hyperlipidemia patients with diabetes mellitus (DM) or prior atherosclerotic cardiovascular diseases (ASCVD) are lacking. Methods: This is a retrospective, longitudinal...
10.
Fukushima A, Khabtheni W, Guelfucci F, Onishi Y, Sugiyama D, Okamura T, et al.
Am J Hypertens . 2018 Nov; 32(3):298-307. PMID: 30475981
Background: Few of studies investigated the effect of antihypertensives among working population. We aimed to describe the impact of hypertension with and without antihypertensives on hospitalizations because of cardiovascular diseases...